Diagnosis and management of staphylococcal infections of pacemakers and cardiac defibrillators

Internal Medicine Journal

Volumn 35, Issue SUPPL. 2, 2005, Pages

  Chambers, S T ^a,b  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cardiac device endocarditis; Defibrillator infections; Pacemaker infections; Pacemaker pocket infections; Staphylococcal infections

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFALEXIN; CEFALOTIN; CEFAZOLIN; CEPHALOSPORIN DERIVATIVE; DICLOXACILLIN; FLUCLOXACILLIN; GENTAMICIN; PENICILLIN DERIVATIVE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIMICROBIAL THERAPY; ARTIFICIAL HEART PACEMAKER; BLOOD CULTURE; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COUGHING; DEFIBRILLATOR; DRUG POTENTIATION; DYSPNEA; HUMAN; PRIORITY JOURNAL; PROSTHESIS INFECTION; REVIEW; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; THORAX PAIN; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; DEVICE REMOVAL; INFECTION;

ANTI-BACTERIAL AGENTS; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; HUMANS; PACEMAKER, ARTIFICIAL; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS;

EID: 33645834352     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1444-0903.2005.00980.x     Document Type: Review

References (67)

1. Choo MH, Holmes DR Jr, Gersh BJ, Maloney JD, Merideth J, Pluth JR et al. Permanent pacemaker infections: characterization and management. Am J Cardiol 1981; 48: 559-64.
2. Gupta S, Prevel CD, Shaheen K, Wilkens E, Smith DJ Jr, Kirsh MM et al. Wound complications and treatment of the infected implantable cardioverter defibrillator generator. J Card Surg 1993; 8: 671-7.
3. Hurst LN, Evans HB, Windle B, Klein GJ. The salvage of infected cardiac pacemaker pockets using a closed irrigation system. Pacing Clin Electrophysiol 1986; 9(6 Pt 1): 785-92.
4. Arber N, Pras E, Copperman Y, Schapiro JM, Meiner V, Lossos IS et al. Pacemaker endocarditis. Report of 44 cases and review of the literature. Medicine (Baltimore) 1994; 73: 299-305.
5. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000; 133: 604-8.
6. Cacoub P, Leprince P, Nataf P, Hausfater P, Dorent R, Wechsler B et al. Pacemaker infective endocarditis. Am J Cardiol 1998; 82: 480-4.
7. Klug D, Lacroix D, Savoye C, Goullard L, Grandmougin D, Hennequin JL et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 1997; 95: 2098-107.
8. Von Reyn CF, Levy BS, Arbeit RD, Friedland G, Crumpacker CS. Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med 1981; 94(4 Pt 1): 505-18.
9. Chamis AL, Peterson GE, Cabell CH, Corey GR, Sorrentino RA, Greenfield RA et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 2001; 104: 1029-33.
10. Aggarwal RK, Connelly DT, Ray SG, Ball J, Charles RG. Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems. Br Heart J 1995; 73: 571-5.
11. Hill PE. Complications of permanent transvenous cardiac pacing: a 14-year review of all transvenous pacemakers inserted at one community hospital. Pacing Clin Electrophysiol 1987; 10: 564-70.
12. Harcombe AA, Newell SA, Ludman PF, Wistow TE, Sharples LD, Schofield PM et al. Late complications following permanent pacemaker implantation or elective unit replacement. Heart 1998; 80: 240-4.
13. Matsuura Y, Yamashina H, Higo M, Fujii T. Analysis of complications of permanent transvenous implantable cardiac pacemaker related to operative and postoperative management in 717 consecutive patients. Hiroshima J Med Sci 1990; 39: 131-7.
14. Frame R, Brodman RF, Furman S, Andrews CA, Gross JN. Surgical removal of infected transvenous pacemaker leads. Pacing Clin Electrophysiol 1993; 16: 2343-8.
15. Fang G, Keys TF, Gentry LO, Harris AA, Rivera N, Getz K et al. Prosthetic valve endocarditis resulting from nosocomial bacteremia. A prospective, multicenter study. Ann Intern Med 1993; 119(7 Pt 1): 560-7.
16. Murdoch DR, Roberts SA, Fowler VG Jr, Shah MA, Taylor SL, Morris AJ et al. Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin Infect Dis 2001; 32: 647-9.
17. Bluhm G, Julander I, Levander-Lindgren M, Olin C. Septicaemia and endocarditis - uncommon but serious complications in connection with permanent cardiac pacing. Scand J Thorac Cardiovasc Surg 1982; 16: 65-70.
18. Glock Y, Sabatier J, Salvador-Mazencq M, Puel P. Endocarditis on cardiac pacemaker endocavitary electrodes. Apropos of 7 cases. Arch Mal Coeur Vaiss 1986; 79: 483-8.
19. Loffler S, Kasper J, Postulka J, Cornak V, Bohunicky F, Zelenay J et al. Septic complications in patients with permanent pacemakers. Cor Vasa 1988; 30: 400-4.
20. Morgan G, Ginks W, Siddons H, Leatham A. Septicemia in patients with an endocardial pacemaker. Am J Cardiol 1979; 44: 221-4.
21. Smyth EG, Pallister D. Septicaemia in patients with temporary and permanent endocardial pacemakers. J R Soc Med 1989; 82: 396-8.
22. Corman LC, Levison ME. Sustained bacteremia and transvenous cardiac pacemakers. JAMA 1975; 233: 264-6.
23. Camus C, Leport C, Raffi F, Michelet C, Cartier F, Vilde JL. Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal. Clin Infect Dis 1993; 17: 46-55.
24. Panidis IP, Kotler MN, Mintz GS, Ross J, Weber J. Clinical and echocardiographic correlations in right heart endocarditis. Int J Cardiol 1984; 6: 17-34.
25. Ginzton LE, Siegel RJ, Criley JM. Natural history of tricuspid valve endocarditis: a two dimensional echocardiographic study. Am J Cardiol 1982; 49: 1853-9.
26. Vilacosta I, Sarria C, San Roman JA, Jimenez J, Castillo JA, Iturralde E et al. Usefulness of transesophageal echocardiography for diagnosis of infected transvenous permanent pacemakers. Circulation 1994; 89: 2684-7.
27. Zehender M, Buchner C, Geibel A, Kasper W, Meinertz T, Just H. Diagnosis of hidden pacemaker lead sepsis by transesophageal echocardiography and a new technique for lead extraction. Am Heart J 1989; 118: 1050-3.
28. Victor F, De Place C, Camus C, Le Breton H, Leclercq C, Pavin D et al. Pacemaker lead infection: echocardiographic features, management, and outcome. Heart 1999; 81: 82-7.
29. Dalal A, Asirvatham SJ, Chandrasekaran K, Seward JB, Tajik AJ. Intracardiac echocardiography in the detection of pacemaker lead endocarditis. J Am Soc Echocardiogr 2002; 15: 1027-8.
30. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990; 263: 2753-9.
31. Blachere H, Latrabe V, Montaudon M, Valli N, Couffinhal T, Raherisson C et al. Pulmonary embolism revealed on helical CT angiography: comparison with ventilation-perfusion radionuclide lung scanning. Am J Roentgenol 2000; 174: 1041-7.
32. Remy-Jardin M, Remy J, Deschildre F, Artaud D, Beregi JP, Hossein-Foucher C et al. Diagnosis of pulmonary embolism with spiral CT: comparison with pulmonary angiography and scintigraphy. Radiology 1996; 200: 699-706.
33. Schoepf UJ, Costello P. CT angiography for diagnosis of pulmonary embolism: state of the art. Radiology 2004; 230: 329-37.
34. Howarth DM, Curteis PG, Gibson S. Infected cardiac pacemaker wires demonstrated by Tc-99m labeled white blood cell scintigraphy. Clin Nucl Med 1998; 23: 74-6.
35. Turkisher V, Priel I, Dan M. Successful management of an infected implantable cardioverter defibrillator with oral antibiotics and without removal of the device. Pacing Clin Electrophysiol 1997; 20(9 Pt 1): 2268-70.
36. Lee JH, Geha AS, Rattehalli NM, Cmolik BL, Johnson NJ, Biblo LA et al. Salvage of infected ICDs: management without removal. Pacing Clin Electrophysiol 1996; 19(4 Pt 1): 437-42.
37. Widmer AF, Frei R, Rajacic Z, Zimmerli W. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 1990; 162: 96-102.
38. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Foreign-Body Infection (FBI) Study Group. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. JAMA 1998; 279: 1537-41.
39. Garcia-Rinaldi R, Revuelta JM, Bonnington L, Soltero-Harrington L. The exposed cardiac pacemaker. Treatment by subfascial pocket relocation. J Thorac Cardiovasc Surg 1985; 89: 136-41.
40. Harjula A, Jarvinen A, Virtanen KS, Mattila S. Pacemaker infections - treatment with total or partial pacemaker system removal. Thorac Cardiovasc Surg 1985; 33: 218-20.
41. Vogt PR, Sagdic K, Lachat M, Candinas R, von Segesser LK, Turina MI. Surgical management of infected permanent transvenous pacemaker systems: ten year experience. J Card Surg 1996; 11: 180-6.
42. Parry G, Goudevenos J, Jameson S, Adams PC, Gold RG. Complications associated with retained pacemaker leads. Pacing Clin Electrophysiol 1991; 14: 1251-7.
43. Rettig G, Doenecke P, Sen S, Volkmer I, Bette L. Complications with retained transvenous pacemaker electrodes. Am Heart J 1979; 98: 587-94.
44. Lewis AB, Hayes DL, Holmes DR Jr, Vlietstra RE, Pluth JR, Osborn MJ. Update on infections involving permanent pacemakers. Characterization and management. J Thorac Cardiovasc Surg 1985; 89: 758-63.
45. Karchmer AW. Infections of prosthetic valves and intravascular devices. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 5th edn. New York: Churchill Livingstone; 2000: 911-17.
46. Karchmer AW, Longworth DL. Infections of intracardiac devices. Cardiol Clin 2003; 21: 253-71, vii.
47. Sande MA, Courtney KB. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis. J Lab Clin Med 1976; 88: 118-24.
48. Abrams B, Sklaver A, Hoffman T, Greenman R. Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers. Ann Intern Med 1979; 90: 789-91.
49. Thompson RL. Staphylococcal infective endocarditis. Mayo Clin Proc 1982; 57: 106-14.
50. Chuard C, Herrmann M, Vaudaux P, Waldvogel FA, Lew DP. Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob Agents Chemother 1991; 35: 2611-16.
51. Karchmer AW, Gibbons GW. Infections of prosthetic heart valves and vascular grafts. In: Bisno AL, Waldvogel FA, eds. Infections Associated with Indwelling Devices, 2nd edn. Washington, DC: American Society for Microbiology; 1994: 213-49.
52. Molina JE. Undertreatment and overtreatment of patients with infected antiarrhythmic implantable devices. Ann Thorac Surg 1997; 63: 504-9.
53. Chambers HF, Miller RT, Newman MD. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med 1988; 109: 619-24.
54. DiNubile MJ. Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users. Ann Intern Med 1994; 121: 873-6.
55. Torres-Tortosa M, de Cueto M, Vergara A, Sanchez-Porto A, Perez-Guzman E, Gonzalez-Serrano M et al. Grupo de Estudio de Enfermedades Infecciosas de la Provincia de Cadiz. Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis. Eur J Clin Microbiol Infect Dis 1994; 13: 559-64.
56. Espinosa FJ, Valdes M, Martin-Luengo F, Arribas JP, Albaladejo J, Perez-Gracia A et al. Right endocarditis caused by Staphylococcus aureus in parenteral drug addicts: evaluation of a combined therapeutic scheme for 2 weeks versus conventional treatment. Enferm Infecc Microbiol Clin 1993; 11: 235-40.
57. Dworkin RJ, Lee BL, Sande MA, Chambers HF. Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet 1989; 2: 1071-3.
58. Heldman AW, Hartert TV, Ray SC, Daoud EG, Kowalski TE, Pompili VJ et al. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med 1996; 101: 68-76.
59. O'Nunain S, Perez I, Roelke M, Osswald S, McGovern BA, Brooks DR et al. The treatment of patients with infected implantable cardioverter-defibrillator systems. J Thorac Cardiovasc Surg 1997; 113: 121-9.
60. Baddour LM. Long-term suppressive antimicrobial therapy for intravascular device-related infections. Am J Med Sci 2001; 322: 209-12.
61. Frame R, Brodman RF, Furman S. Infections of nonthoracotomy ICD leads: a note of caution. Pacing Clin Electrophysiol 1993; 16: 2215-16.
62. Alt E, Neuzner J, Binner L, Gohl K, Res JC, Knabe UH et al. Three-year experience with a stylet for lead extraction: a multicenter study. Pacing Clin Electrophysiol 1996; 19: 18-25.
63. Smith HJ, Fearnot NE, Byrd CL, Wilkoff BL, Love CJ, Sellers TD. Five-years experience with intravascular lead extraction. U.S. Lead Extraction Database. Pacing Clin Electrophysiol 1994; 17: 2016-20.
64. Wilkoff BL, Byrd CL, Love CJ, Hayes DL, Sellers TD, Schaerf R et al. Pacemaker lead extraction with the laser sheath: results of the pacing lead extraction with the excimer sheath (PLEXES) trial. J Am Coll Cardiol 1999; 33: 1671-6.
65. Reiser C, Taylor KD, Lippincott RA. Large laser sheaths for pacing and defibrillator lead removal. Lasers Surg Med 1998; 22: 42-5.
66. Mugge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol 1989; 14: 631-8.
67. Robbins MJ, Frater RW, Soeiro R, Frishman WH, Strom JA. Influence of vegetation size on clinical outcome of right-sided infective endocarditis. Am J Med 1986; 80: 165-71.